Paul Huang, n/a

The Institute for Cancer Research
London, England, United Kingdom

Presentation(s):

• Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS

  Saturday, November 19, 2022
  8:40 AM – 8:48 AM